TRT LSE Week ended 24 Jul 2026

Weekly Investor Report

Transense Technologies plc · Consumer Cyclical · Auto Parts

Open interactive chart View report data
Latest close 0.51 GBP
4.1% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -27.5% below the Trend Line and sits at 3.6% of its 52-week range. The latest completed week returned 4.1%, after a 5.2% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 45/100.

Setup score 19 out of 100
Latest Close 0.51 GBP 24 Jul 2026
1W Return 4.1% latest completed week
4W Return 5.2% short-term follow-through
12W Return -13.7% quarterly tape
Trend Breadth 3.8% 2 of 52 weeks active
Volume Ratio 1.0x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 4.1% Latest completed week; four-week move 5.2%. Indicator stack 2/8 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 39.82% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 45/100 4 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -27.5% below the Trend Line and sits at 3.6% of its 52-week range. The latest completed week returned 4.1%, after a 5.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0112-week average 0.06

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.01Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 5.2% over four weeks, -13.7% over 12 weeks, and -65.3% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W4.1%
4W5.2%
12W-13.7%
26W-58.8%
52W-65.3%
Active trend streak0 weeks
Active weeks in one year2
Trend breadth3.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.33Latest activity-pressure read.
Pressure change-451.2%Four-week change in activity pressure.
Leadership-50.30Latest relative-leadership reading.
RS change10.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 30 Jun 2025 Field coverage 88% Model confidence 72%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength10/100Blend of value, momentum, and quality. Underlying universe rank 91; rank 1 is best.
Value24/100Relative valuation strength. Underlying universe rank 77; rank 1 is best.
Quality25/100Profitability and accounting quality. Underlying universe rank 76; rank 1 is best.
Momentum25/100Medium-term price momentum. Underlying universe rank 76; rank 1 is best.
Growth25/100Revenue and earnings growth. Underlying universe rank 76; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework94/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.0x
Market value relative to trailing revenue.
EV / EBITDA
0.0x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-59.8%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
89.2%
Gross profit retained from each unit of revenue.
Operating margin
27.3%
Operating profit retained from revenue.
Free-cash-flow margin
-0.9%
Free cash flow generated from revenue.
Return on invested capital
15.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
23.5%
Latest one-year revenue growth.
EPS growth
-10.0%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-106.8%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.3x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment45/100

Weighted news tone is neutral across 4 relevant articles.

0 positive · 3 neutral · 1 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-65.3%Distance below the 52-week high.
13-week volatility5.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher10 of 2614 weeks finished lower.
Best week+6.0%Week of 8 May.
Worst week-40.8%Week of 30 Jan.
Latest week+4.1%Week of 24 Jul.

Shape of recent returns

Strong gains5
Modest gains5
Flat weeks2
Modest losses7
Sharp losses7
Recent vol5.1%13-week weekly-return volatility.
Base vol7.4%52-week weekly-return volatility.
Up/down split18/29Count of positive and negative weeks in the 52-week window.
Average skew3.8% / -5.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape13/100

Trend, activity pressure, participation, and risk combine to a 13/100 tape read.

 Indicator analysis14/100

Latest 12-week confirmation: trend 0/12, activity pressure 3/12, relative leadership 0/12.

Activity pressure 0.01; No reversal markers Next-Week ExpectancyNegative 39.82%

Next-week expectancy is negative with a 39.82% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors19/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 68 SVQF94/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 22.0 of 351 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Sentiment45/100

Weighted news tone is neutral across 4 relevant articles.

REG - Transense Technlgy - Director/PDMR Shareholding - acquisition of shares Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 20260.51 GBP4.1%0.70 GBP1.18 GBP-0.33-50.30115.9KOff
17 Jul 20260.48 GBP0.0%0.73 GBP1.18 GBP-0.30-52.7321.5KOff
10 Jul 20260.48 GBP0.0%0.76 GBP1.18 GBP-0.23-53.3122.2KOff
3 Jul 20260.48 GBP1.0%0.78 GBP1.18 GBP-0.15-55.24175.3KOff
26 Jun 20260.48 GBP-15.0%0.81 GBP1.19 GBP-0.06-56.09386.2KOff
19 Jun 20260.56 GBP0.9%0.83 GBP1.19 GBP-0.07-48.8832.5KOff
12 Jun 20260.56 GBP-2.6%0.85 GBP1.19 GBP0.02-50.9834.0KOff
5 Jun 20260.57 GBP-5.0%0.87 GBP1.19 GBP0.11-50.33193.1KOff
29 May 20260.60 GBP-0.8%0.89 GBP1.19 GBP0.09-49.1227.0KOff
22 May 20260.61 GBP-2.4%0.91 GBP1.20 GBP-0.07-49.8888.0KOff
15 May 20260.62 GBP0.8%0.93 GBP1.20 GBP-0.31-48.1992.1KOff
8 May 20260.62 GBP6.0%0.94 GBP1.20 GBP-0.57-49.4755.8KOff
1 May 20260.58 GBP4.5%0.96 GBP1.20 GBP-0.82-53.58323.3KOff
24 Apr 20260.56 GBP-10.0%0.98 GBP1.20 GBP-0.92-56.29388.1KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.